江苏悦兴药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
106
NMPA:106
Drug Approvals
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 盐酸莫西沙星氯化钠注射液
- Approval Number
- 国药准字H20234493
- Approval Date
- Nov 21, 2023
NMPA
Rosuvastatin Calcium Tablets
- Product Name
- 瑞舒伐他汀钙片
- Approval Number
- 国药准字H20223483
- Approval Date
- Jul 7, 2022
NMPA
Gentamycin Sulfate Injection
- Product Name
- 硫酸庆大霉素注射液
- Approval Number
- 国药准字H32022457
- Approval Date
- Aug 31, 2020
NMPA
Paracetamol and Pseudoephedrine Hydrochloride Tablets（Ⅱ）
- Product Name
- 劲得
- Approval Number
- 国药准字H10950335
- Approval Date
- Aug 24, 2020
NMPA
Acetylspiramycin Capsules
- Product Name
- 乙酰螺旋霉素胶囊
- Approval Number
- 国药准字H32024832
- Approval Date
- Aug 24, 2020
NMPA
Procaine Hydrochloride Injection
- Product Name
- 盐酸普鲁卡因注射液
- Approval Number
- 国药准字H32024570
- Approval Date
- Aug 24, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found